{"id":"https://openalex.org/W2907073897","doi":"https://doi.org/10.1182/blood-2018-99-117297","title":"Clonal Suppression of TP53 Mutant MDS and Oligoblastic AML with Hypomethylating Agent Therapy Improves Overall Survival","display_name":"Clonal Suppression of TP53 Mutant MDS and Oligoblastic AML with Hypomethylating Agent Therapy Improves Overall Survival","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2907073897","doi":"https://doi.org/10.1182/blood-2018-99-117297","mag":"2907073897"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-117297","doi":"https://doi.org/10.1182/blood-2018-99-117297","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-117297","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029369362","display_name":"David Andrew Sallman","orcid":"https://orcid.org/0000-0003-0504-8233","observed_orcids":["https://orcid.org/0000-0003-0504-8233"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A Sallman","raw_affiliation_strings":["Malignant Hematology Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061883803","display_name":"Najla E. Al Ali","orcid":"https://orcid.org/0009-0002-1509-6319","observed_orcids":["https://orcid.org/0009-0002-1509-6319"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Najla Al Ali","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011096418","display_name":"Seongseok Yun","orcid":"https://orcid.org/0000-0001-7343-1635","observed_orcids":["https://orcid.org/0000-0001-7343-1635"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Seongseok Yun","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041754278","display_name":"Eric Padron","orcid":"https://orcid.org/0000-0002-4707-7916","observed_orcids":["https://orcid.org/0000-0002-4707-7916"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Padron","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017013442","display_name":"Jinming Song","orcid":"https://orcid.org/0000-0001-5642-1451","observed_orcids":["https://orcid.org/0000-0001-5642-1451"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jinming Song","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047282995","display_name":"Mohammad Hussaini","orcid":"https://orcid.org/0000-0001-5192-0489","observed_orcids":["https://orcid.org/0000-0001-5192-0489"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mohammad Omar Hussaini","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078822704","display_name":"Chetasi Talati","orcid":"https://orcid.org/0000-0002-2246-213X","observed_orcids":["https://orcid.org/0000-0002-2246-213X"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chetasi Talati","raw_affiliation_strings":["Division of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057933586","display_name":"Kendra Lynn Sweet","orcid":"https://orcid.org/0000-0001-6248-3317","observed_orcids":["https://orcid.org/0000-0001-6248-3317"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kendra L. Sweet","raw_affiliation_strings":["Malignant Hematology Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041443589","display_name":"Jeffrey E. Lancet","orcid":"https://orcid.org/0000-0002-7751-7310","observed_orcids":["https://orcid.org/0000-0002-7751-7310"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey E. Lancet","raw_affiliation_strings":["Malignant Hematology Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066001318","display_name":"Alan F. List","orcid":"https://orcid.org/0000-0002-1647-2972","observed_orcids":["https://orcid.org/0000-0002-1647-2972"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan F. List","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010075752","display_name":"Rami S. Komrokji","orcid":"https://orcid.org/0000-0002-1876-5269","observed_orcids":["https://orcid.org/0000-0002-1876-5269"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rami S. Komrokji","raw_affiliation_strings":["Malignant Hematology Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Malignant Hematology Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5017013442","https://openalex.org/A5047282995","https://openalex.org/A5061883803"],"corresponding_institution_ids":["https://openalex.org/I3019308854"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"1817","last_page":"1817"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9549999833106995},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9710000157356262},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.9610000252723694},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.984000027179718},{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/clonal-evolution","display_name":"clonal evolution","score":0.4650000035762787},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.5270000100135803},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.42100000381469727},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9089999794960022},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.675000011920929},{"id":"https://openalex.org/keywords/molecular-profiling","display_name":"molecular profiling","score":0.30799999833106995},{"id":"https://openalex.org/keywords/refractory-disease","display_name":"refractory disease","score":0.5569999814033508},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.3310000002384186}],"concepts":[{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.867243766784668},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7461879253387451},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.7138936519622803},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6784090995788574},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6022475361824036},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.548289954662323},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.5393632650375366},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.5077191591262817},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.45758381485939026},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.2887374758720398},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.14598247408866882},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.12782174348831177},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12614241242408752},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12390449643135071},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-117297","doi":"https://doi.org/10.1182/blood-2018-99-117297","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-117297","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2908599157","https://openalex.org/W2538106848","https://openalex.org/W3213378371","https://openalex.org/W3132690588","https://openalex.org/W2304376138","https://openalex.org/W3040668663","https://openalex.org/W2588298595","https://openalex.org/W2987612176","https://openalex.org/W2988372748","https://openalex.org/W2479163287"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Hypomethylating":[2],"agent":[3],"(HMA)":[4],"therapy":[5,611,690],"represents":[6],"the":[7,44,94,151,172,187,207,232,294,352,393,397],"standard":[8],"of":[9,22,46,125,161,174,179,190,201,209,234,241,250,264,277,297,333,396,441,503,633],"care":[10],"for":[11,52,217,512,533],"patients":[12,23,129,158,203,244,253,266,286,298,455,578,604,648,666],"with":[13,267,273,302,306,311,317,322,325,360,378,580,609,653,672,687],"higher":[14,573,634],"risk":[15,574,635],"myelodysplastic":[16],"syndromes":[17],"(MDS)":[18],"although":[19],"only":[20],"50%":[21],"respond":[24],"to":[25,43,54,122,165,171,224,247,259,344,443,460,480,520,572,621,696],"treatment.":[26],"Recent":[27],"evidence":[28],"from":[29,150,231],"molecular":[30],"profiling":[31],"through":[32],"next-generation":[33],"sequencing":[34],"(NGS)":[35],"in":[36,68,98,291,313,371,375,407,545,586,657],"myeloid":[37,75],"diseases":[38],"has":[39],"been":[40,60],"conflicting":[41,61],"as":[42,49,682,684],"value":[45],"somatic":[47],"mutations":[48,290],"a":[50,248,262,274,387,531,557],"biomarker":[51],"response":[53,64,364,459,658],"HMA.":[55,175,663],"In":[56,487,600,629],"particular,":[57],"there":[58,582],"have":[59,649,679],"data":[62],"on":[63,79,111],"rates":[65,238,596,659],"and":[66,73,108,136,141,163,186,199,229,239,281,319,383,637],"outcomes":[67,124,200,240,442,661],"TP53":[69,95,126,138,162,242,268,428,453,505,551,576,602,646,664,692],"mutant":[70,96,127,269],"(MT)":[71],"MDS":[72,128,140,155,202,270,636],"acute":[74],"leukemia":[76],"(AML)":[77],"based":[78,110],"azacitidine":[80,303],"versus":[81,116],"decitabine":[82],"(Welch":[83],"et":[84,89],"al.,":[85,90],"NEJM":[86,91],"2016;":[87],"Garcia-Manero":[88],"2017).":[92],"However,":[93,452],"cohorts":[97],"these":[99],"studies":[100],"were":[101,147,204,215,222,245,271,300],"small":[102],"(median":[103],"23":[104],"patients,":[105],"range":[106],"13-39)":[107],"heterogeneous":[109],"treatment":[112,674],"status":[113],"(treatment":[114],"na\u00efve":[115],"relapse/refractory).":[117],"Therefore,":[118],"our":[119],"goal":[120],"was":[121,182,195,336,368,400,404,438,583],"characterize":[123],"who":[130,456,526,548,555,641,667],"received":[131,642],"frontline":[132,643],"HMA":[133,235,334,444,461,610,644,673],"therapy.":[134],"Patients":[135],"Methods":[137],"MT":[139,243,454,603,647,665],"oligoblastic":[142,638],"AML":[143,639],"(20-30%":[144],"blasts)":[145],"cases":[146],"retrospectively":[148],"identified":[149,272],"Moffitt":[152],"Cancer":[153],"Center":[154],"database.":[156],"All":[157],"had":[159,288,457,468,530,549,561,605],"NGS":[160,552],"up":[164,390],"53":[166],"additional":[167],"genes":[168],"performed":[169],"prior":[170],"initiation":[173],"The":[176,330],"lower":[177],"limit":[178],"VAF":[180,463,558,676],"detection":[181],"set":[183],"at":[184,192,206],"5%":[185,560],"minimum":[188],"depth":[189],"coverage":[191],"each":[193],"position":[194],"500X.":[196],"Clinical":[197],"variables":[198],"characterized":[205],"time":[208],"sample":[210],"procurement.":[211],"Fisher's":[212],"exact":[213],"tests":[214],"used":[216,223],"comparative":[218],"analyses.":[219],"Kaplan-Meier":[220],"curves":[221],"estimate":[225],"overall":[226,363],"survival":[227],"(OS)":[228],"analyzed":[230],"date":[233],"initiation.":[236],"Response":[237],"compared":[246],"cohort":[249,399,632],"wildtype":[251],"(WT)":[252],"(n=63).":[254],"Results":[255],"From":[256],"May":[257,260],"2013":[258],"2018,":[261],"total":[263],"71":[265],"median":[275,331,388,394,408],"age":[276],"68":[278],"years":[279],"(39-82)":[280],"male":[282],"predominance":[283],"(66%).":[284],"Fourteen":[285],"(20%)":[287],"multiple":[289],"TP53.":[292],"Of":[293,351],"cohort,":[295,353],"82%":[296],"(n=58)":[299],"treated":[301,377,579],"(88%":[304],"(n=51)":[305],"AZA":[307,312,379,411,413],"monotherapy;":[308],"12%":[309],"(n=7)":[310],"combination":[314],"(2":[315],"pts":[316,321,341,376,547,554,640],"lenalidomide":[318],"5":[320],"investigational":[323],"agents))":[324],"18%":[326,354],"(n=13)":[327,355,529],"receiving":[328],"decitabine.":[329],"#":[332],"cycles":[335],"4":[337],"(range":[338],"1-33).":[339],"Thirteen":[340],"(18%)":[342],"proceeded":[343],"allogeneic":[345],"hematopoietic":[346],"stem":[347],"cell":[348],"transplant":[349],"(HSCT).":[350],"obtained":[356],"complete":[357],"remission":[358],"(CR)":[359],"39%":[361],"(n=28)":[362],"rate":[365],"(ORR).":[366],"There":[367,403],"no":[369,405,584,654],"difference":[370,406,585],"CR":[372,587],"or":[373,501,594,660],"ORR":[374,595],"vs":[380,412,415,418,420,435,446,472,538,567,589,598,613],"DAC":[381,416],"(P=0.24":[382],"P=0.2,":[384],"respectively).":[385],"At":[386],"follow":[389],"20":[391],"months,":[392,448],"OS":[395,409,470,514,535,564,608,652,681],"entire":[398],"9.7":[401],"months.":[402],"between":[410],"combo":[414],"(7.6":[417],"15.2":[419],"12.5":[421],"months;":[422,474,540,569,615],"P":[423,449,482,522,541,623],"=":[424,450,483,523,542,592,624],"0.44;":[425],"Figure":[426,485,626,699,701],"1A).":[427],"variant":[429],"allele":[430],"frequency":[431],"(VAF":[432],">":[433],"20%":[434],"\u2264":[436],"20%)":[437],"not":[439],"predictive":[440],"(7.8":[445],"10.4":[447],"0.36).":[451],"clonal":[458,506,670],"(i.e.":[462,675],"<":[464,559,677],"5%;":[465],"n=19":[466],"(27%))":[467],"improved":[469,513,534,563,680,685],"(14.5":[471,536],"7.5":[473],"HR":[475,616],"0.33,":[476],"95%":[477,517,618],"CI":[478,518,619],"0.18":[479],"0.59;":[481],"0.001;":[484,625],"1B).":[486],"multivariable":[488],"analysis":[489],"incorporating":[490],"age,":[491],"revised":[492],"international":[493],"prognostic":[494],"scoring":[495],"system":[496],"(IPSS-R)":[497],"category,":[498],"HSCT":[499,528],"status,":[500],"type":[502],"HMA,":[504,581],"clearance":[507],"remained":[508],"an":[509],"independent":[510],"covariate":[511],"(HR":[515],"0.34,":[516],"0.16":[519],"0.72;":[521],"0.005).":[524],"Pts":[525],"underwent":[527],"trend":[532],"months":[537,566],"7.9":[539],"0.09).":[543],"Notably":[544],"transplanted":[546],"serial":[550],"(n=7),":[553],"achieved":[556],"significant":[562,655],"(16.3":[565],"8.9":[568],"P=0.03).":[570],"Compared":[571],"MDS/AML":[575],"WT":[577],"(18%":[588],"14%":[590],"(P":[591],"0.64)":[593],"(39%":[597],"40%).":[599],"contrast,":[601],"significantly":[606,650],"inferior":[607,651],"(9.7":[612],"15.4":[614],"2.14,":[617],"1.32.":[620],"3.27;":[622],"1C).":[627],"Conclusion":[628],"this":[630],"large":[631],"therapy,":[645],"differences":[656],"by":[662],"achieve":[668],"maximum":[669],"suppression":[671],"5%)":[678],"well":[683],"outcome":[686],"HSCT.":[688],"Novel":[689],"targeting":[691],"mutation":[693],"is":[694],"needed":[695],"improve":[697],"outcomes.":[698],"1.":[700,702],"Disclosures":[703],"Sallman:":[704],"Celgene:":[705,726,744,757,769],"Research":[706,751,759,771],"Funding,":[707],"Speakers":[708,713,724,728,733,738,746,755,763,767,775],"Bureau.":[709,776],"Sweet:Agios:":[710],"Consultancy;":[711,716,718,720,722,741],"Jazz:":[712,723],"Bureau;":[714,725,729,734,739,747,756,764,768],"Astellas:":[715,721],"Phizer:":[717,719],"Honoraria,":[727,732,737,745,754,758,762,766,770,774],"Novartis:":[730,735,761,765,773],"Consultancy,":[731,736],"Agios:":[740],"BMS:":[742,748],"Honoraria;":[743],"Honoraria.":[749],"List:Celgene:":[750],"Funding.":[752],"Komrokji:Novartis:":[753],"Funding;":[760,772]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2019-01-11T00:00:00"}